Saturday | 30 August, 2008
Australian Biotechnology News

Biotech news: News

News
  • +

    No pain for Xenome 21/08/2008 16:36:00

    Synthetic venom peptide shows promise in trials
    Synthetic venom peptide shows promise in trials
  • +

    QRXPharma writes off 21/08/2008 16:16:00

    QRxPharma reports $36 million deficit
    QRxPharma reports $36 million deficit
  • +

    Spine fusion for Mesoblast 21/08/2008 16:21:00

    Mesoblast's stem cells effective method for cervical spine fusion
    Mesoblast's stem cells effective method for cervical spine fusion
  • +

    Anadis fights flu 20/08/2008 12:17:00

    Anadis shows proof-of-principle for spray-based 'flu fighter'
    Anadis shows proof-of-principle for spray-based 'flu fighter'
  • +

    Happy as a pig 20/08/2008 16:04:00

    Imugene reports early PRRS vaccine trial results
    Imugene reports early PRRS vaccine trial results
  • +

    Good dose for Viralytics 20/08/2008 12:32:00

    Viralytics progresses through Phase 1 trial of Cavatak
    Viralytics progresses through Phase 1 trial of Cavatak
  • +

    Market in sight for Pharmaxis 20/08/2008 16:12:00

    Pharmaxis concludes Phase 3 trial of Bronchitol
    Pharmaxis concludes Phase 3 trial of Bronchitol
  • +

    Aldridge quits Peplin 19/08/2008 17:00:00

    Peplin appoints new CEO and president/CMO
    Peplin appoints new CEO and president/CMO
  • +

    Streaking ahead for microbiology 18/08/2008 12:52:00

    For such a simple idea, it’s a surprise that no one has thought of it before. An automated system for streaking agar plates is on the market, developed here in Australia.
    For such a simple idea, it’s a surprise that no one has thought of it before. An automated system for streaking agar plates is on the market, developed here in Australia.
  • +

    Life's Full Court appeal accepted 15/08/2008 14:35:00

    Life's legal battle with Bell IXL will continue, after the Full Court ordered a retrial.
    Life's legal battle with Bell IXL will continue, after the Full Court ordered a retrial.
  • +

    Acrux-Organon partnership dropped 15/08/2008 15:00:00

    Schering-Plough cancels two projects with Acrux
    Schering-Plough cancels two projects with Acrux
Additional Resources

Newsletter Subscription

Sign up for our Australian Life Scientist newsletters!
The latest, most important headlines from Australia and around the world.
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.

Australian Life Scientist Member Login

 
Sponsored Links